SEC Form 4 · accession 0001140361-16-054573
BIOMARIN PHARMACEUTICAL INC · BMRN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael G Grey
Director
Period of report
Feb 22, 2016
Accepted (ET)
Feb 23, 2016 · 4:41 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001048477
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Feb 22, 2016 | M | 7,500 | $38.59 | A | 33,750 | D | |
| Common StockF1,F2 | Feb 22, 2016 | S | 7,500 | $80.00 | D | 26,250 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Common StockF1,F4,F3 | $38.59 | Feb 22, 2016 | M | 7,500 | D | Nov 22, 2008 | May 21, 2018 | Common Stock | 7,500 | 0 | D |
Explanation of responses
- F1Trade made pursuant to a 10b5-1 plan executed on August 14, 2015.
- F2All shares were sold at exactly $80.00.
- F3Original option grant vests 6/48ths on November 22, 2008, and 1/48th on the 22nd day of every month thereafter.
- F4Reflects the number of stock options that remain from this specific stock option grant following the reported transaction.